SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 416 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,179,616 | -5.6% | 397,456 | -10.8% | 0.28% | -3.1% |
| Q2 2023 | $51,027,020 | -23.2% | 445,573 | -7.6% | 0.29% | -27.8% |
| Q1 2023 | $66,433,509 | +7.7% | 481,996 | +1.3% | 0.41% | -2.4% |
| Q4 2022 | $61,667,252 | +11.1% | 475,901 | -5.2% | 0.42% | -5.0% |
| Q3 2022 | $55,512,000 | +69.9% | 502,193 | +15.2% | 0.44% | +73.5% |
| Q2 2022 | $32,668,000 | -4.5% | 435,810 | -0.5% | 0.25% | +10.0% |
| Q1 2022 | $34,220,000 | -11.4% | 438,045 | +2.2% | 0.23% | -11.2% |
| Q4 2021 | $38,607,000 | +326.9% | 428,734 | +338.4% | 0.26% | +324.6% |
| Q3 2021 | $9,043,000 | +25.1% | 97,785 | +5.2% | 0.06% | +24.5% |
| Q2 2021 | $7,226,000 | +8.9% | 92,950 | +4.4% | 0.05% | -3.9% |
| Q1 2021 | $6,633,000 | +1305.3% | 88,997 | +2924.0% | 0.05% | +920.0% |
| Q2 2020 | $472,000 | +35.2% | 2,943 | -83.9% | 0.01% | -28.6% |
| Q2 2016 | $349,000 | – | 18,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |